These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1401649)
21. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma. Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398 [TBL] [Abstract][Full Text] [Related]
23. High-dose inhaled versus intravenous salbutamol combined with theophylline in severe acute asthma. Swedish Society of Chest Medicine. Eur Respir J; 1990 Feb; 3(2):163-70. PubMed ID: 2178964 [TBL] [Abstract][Full Text] [Related]
24. Oral fenoterol versus sustained release theophylline in adult asthmatics. Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437 [TBL] [Abstract][Full Text] [Related]
25. Intravenous theophylline in pediatric status asthmaticus. A prospective, randomized, double-blind, placebo-controlled trial. Bien JP; Bloom MD; Evans RL; Specker B; O'Brien KP Clin Pediatr (Phila); 1995 Sep; 34(9):475-81. PubMed ID: 7586920 [TBL] [Abstract][Full Text] [Related]
26. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Simons FE; Gerstner TV; Cheang MS Pediatrics; 1997 May; 99(5):655-9. PubMed ID: 9113940 [TBL] [Abstract][Full Text] [Related]
28. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W; Levine B; Andriano K; Lavecchia C; Yegen U Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475 [TBL] [Abstract][Full Text] [Related]
29. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137 [TBL] [Abstract][Full Text] [Related]
30. [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance]. Ukena D; Koper I; Braun H; Leutz M; Schlimmer P; Sybrecht GW Pneumologie; 1997 Mar; 51(3):317-23. PubMed ID: 9173422 [TBL] [Abstract][Full Text] [Related]
31. Dose of inhaled beta 2-agonists in asthma. Haahtela T; Nyberg A; Laurikainen K; Silvasti M; Vidgren M Lancet; 1991 Mar; 337(8742):684. PubMed ID: 1672032 [No Abstract] [Full Text] [Related]
32. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial. Goldstein MF; Chervinsky P Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074 [TBL] [Abstract][Full Text] [Related]
33. Fluticasone propionate compared with theophylline for mild-to-moderate asthma. Galant SP; Lawrence M; Meltzer EO; Tomasko M; Baker KA; Kellerman DJ Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776 [TBL] [Abstract][Full Text] [Related]
34. The use of a single daily theophylline dose and metered-dose albuterol in asthma treatment. Weinberger M J Allergy Clin Immunol; 1987 Dec; 80(6):891-3. PubMed ID: 3693765 [No Abstract] [Full Text] [Related]
35. Reproducibility and utility of an overnight 0.25 mg dexamethasone suppression test as a marker for glucocorticoid sensitivity in children with asthma. Willemsen RH; van Leeuwen L; Voorend-van Bergen TA; de Rijke YB; Pijnenburg MW; van den Akker EL J Endocrinol Invest; 2016 Jan; 39(1):93-6. PubMed ID: 26059835 [TBL] [Abstract][Full Text] [Related]
36. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I; Hall IP; McFarlane LC; Lipworth BJ J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449 [TBL] [Abstract][Full Text] [Related]
37. The role of glucocorticoids in the management of asthma. Spahn JD; Leung DY Allergy Asthma Proc; 1996; 17(6):341-50. PubMed ID: 8993728 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. Spahn JD; Leung DY; Chan MT; Szefler SJ; Gelfand EW J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):421-6. PubMed ID: 10069875 [TBL] [Abstract][Full Text] [Related]
39. Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol. Lipworth BJ; Jackson CM Chest; 2002 Apr; 121(4):1382. PubMed ID: 11948092 [No Abstract] [Full Text] [Related]
40. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma. Patel M; Pilcher J; Reddel HK; Qi V; Mackey B; Tranquilino T; Shaw D; Black P; Weatherall M; Beasley R; J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]